RC
AGN

Roundview Capital’s Allergan plc AGN Stock Holding History

Roundview Capital’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-3,932
Closed -$956K – 241
2017
Q2 		$956K Sell
3,932
-595
-13% -$140K 0.28% 102
2017
Q1 		$1.08M Buy
4,527
+1,880
+71% +$438K 0.34% 99
2016
Q4 		$556K Buy
2,647
+940
+55% +$195K 0.18% 138
2016
Q3 		$393K Sell
1,707
-25
-1% -$6.11K 0.14% 150
2016
Q2 		$400K Buy
1,732
+440
+34% +$101K 0.15% 142
2016
Q1 		$346K Sell
1,292
-1,280
-50% -$366K 0.13% 146
2015
Q4 		$804K Buy
+2,572
New +$766K 0.32% 90

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Roundview Capital's AGN Position: Q3 2017 in Review

Roundview Capital sold out of Allergan plc (AGN) in Q3 2017, closing a stake of 3,932 shares — an estimated $956K sold.

Roundview Capital first reported a position in AGN in Q4 2015 and held it in 7 quarters. The position peaked at $1.08M in Q1 2017. 1,090 funds tracked by Wall St. Rank hold AGN as of Q3 2017.

  • Roundview Capital reported no remaining Allergan plc position as of Q3 2017 after selling out during the quarter.
  • Roundview Capital sold 3,932 Allergan plc shares in Q3 2017, an estimated $956K.
  • Roundview Capital first reported a position in Allergan plc in Q4 2015 and held it in 7 quarters.
  • Roundview Capital's Allergan plc position peaked at $1.08M in Q1 2017.
  • 1,090 funds tracked by Wall St. Rank held Allergan plc as of Q3 2017.

Based on Roundview Capital's 13F filing for Q3 2017, filed 13 Nov 2017.